CVRx, Inc. is a commercial-stage medical device company specializing in the development and commercialization of neuromodulation therapies for the treatment of cardiovascular diseases, most notably heart failure. Headquartered in Minneapolis, Minnesota, the company pioneered Baroreflex Activation Therapy using its proprietary Barostim system. By engaging the body's natural cardiovascular regulation mechanisms via electrical stimulation of the carotid sinus, CVRx provides an alternative therapeutic pathway for patients who remain symptomatic despite optimal guideline-directed medical therapy.